scholarly journals Marital Status and Survival of Patients with Hormone Receptor-Positive Male Breast Cancer: A Surveillance, Epidemiology, and End Results (SEER) Population-Based Study

2018 ◽  
Vol 24 ◽  
pp. 3425-3441 ◽  
Author(s):  
Lei Liu ◽  
Ya-Yun Chi ◽  
An-An Wang ◽  
Yonghui Luo
Keyword(s):  
Breast Cancer ◽  
Marital Status ◽  
Male Breast Cancer ◽  
Hormone Receptor ◽  
Population Based ◽  
Male Breast ◽  
Population Based Study ◽  
Hormone Receptor Positive ◽  
End Results

scholarly journals Effects of HER2 status on the prognosis of male breast cancer: a population-based study

2019 ◽  
Vol Volume 12 ◽  
pp. 7251-7260 ◽  
Author(s):  
Liang Chen ◽  
Yi Ming Weng ◽  
Meng Xue Hu ◽  
Min Peng ◽  
Qi bin Song
Keyword(s):  
Breast Cancer ◽  
Male Breast Cancer ◽  
Population Based ◽  
Male Breast ◽  
Her2 Status ◽  
Population Based Study

scholarly journals BRCA1 and BRCA2 mutations in a population-based study of male breast cancer

2001 ◽  
Vol 4 (1) ◽  
Author(s):  
Victoria M Basham ◽  
Julian M Lipscombe ◽  
Joanna M Ward ◽  
Simon A Gayther ◽  
Bruce AJ Ponder ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Male Breast Cancer ◽  
Population Based ◽  
Male Breast ◽  
Brca1 And Brca2 ◽  
Population Based Study ◽  
Brca2 Mutations ◽  
Brca1 And Brca2 Mutations

scholarly journals PALB2 mutations in male breast cancer: a population-based study in Central Italy

2010 ◽  
Vol 122 (1) ◽  
pp. 299-301 ◽  
Author(s):  
Valentina Silvestri ◽  
Piera Rizzolo ◽  
Ines Zanna ◽  
Mario Falchetti ◽  
Giovanna Masala ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Male Breast Cancer ◽  
Central Italy ◽  
Population Based ◽  
Male Breast ◽  
Population Based Study

scholarly journals Incidence and Outcome of Male Breast Cancer: An International Population-Based Study

2011 ◽  
Vol 29 (33) ◽  
pp. 4381-4386 ◽  
Author(s):  
Hui Miao ◽  
Helena M. Verkooijen ◽  
Kee-Seng Chia ◽  
Christine Bouchardy ◽  
Eero Pukkala ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Male Breast Cancer ◽  
Relative Survival ◽  
Population Based ◽  
Male Breast ◽  
Survival Ratio ◽  
Population Based Study ◽  
Female Patients ◽  
Risk Of Death ◽  
Male Patients

Purpose Male breast cancer is a rare disease with an incidence rate less than 1% of that of female breast cancer. Given its low incidence, few studies have assessed risk and prognosis. Methods This population-based study, including 459,846 women and 2,665 men diagnosed with breast cancer in Denmark, Finland, Geneva, Norway, Singapore, and Sweden over the last 40 years, compares trends in incidence, relative survival, and relative excess mortality between the sexes. Results World standardized incidence rates of breast cancer were 66.7 per 105 person-years in women and 0.40 per 105 person-years in men. Women were diagnosed at a younger median age (61.7 years) than men (69.6 years). Male patients had a poorer 5-year relative survival ratio than women (0.72 [95% CI, 0.70 to 0.75] v 0.78 [95% CI, 0.78 to 0.78], respectively), corresponding to a relative excess risk (RER) of 1.27 (95% CI, 1.13 to 1.42). However, after adjustment for age and year of diagnosis, stage, and treatment, male patients had a significantly better relative survival from breast cancer than female patients (RER, 0.78; 95% CI, 0.62 to 0.97). Conclusion Male patients with breast cancer have later onset of disease and more advanced disease than female patients. Male patients with breast cancer have lower risk of death from breast cancer than comparable female patients.

Sign in / Sign up

Export Citation Format

Share Document